Structural Heart

Edwards Lifesciences Corp. announced that it has agreed to acquire CardiAQ Valve Technologies Inc., a privately held company and developer of a transcatheter mitral valve replacement (TMVR) system.

CardiAQ Valve Technologies (CardiAQ) announced that its second-generation transcatheter bioprosthetic mitral heart valve was successfully implanted as a compassionate treatment. The device was placed into a 72-year-old male suffering from sev...

Cardiac Dimensions announced the first patients have been enrolled in the REDUCE FMR clinical trial. REDUCE FMR is a prospective, double-blind, randomized multi-center trial, evaluating the company’s minimally-invasive Carillon Mitr...

The American College of Cardiology (ACC), Heart Rhythm Society (HRS) and Society for Cardiovascular Angiography and Interventions (SCAI) released a new overview on the implantation of left atrial appendage occlusion devices.

Direct Flow Medical, Transcatheter Aortic Valve System, SALUS Trial, FDA
Direct Flow Medical Inc. received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) in April to broaden its...
GlobalData, TAVR, Edwards, Medtronic, CoreValve Evolut R, Sapien 3
The recent U.S. Food and Drug Administration (FDA) approvals of two next-generation transcatheter aortic valve replacements (TAVR) devices will transform the U...
Biotronik, TAVI device, BIOVALVE trial, Hamburg, Germany
Biotronik announced the completion of the BIOVALVE first-in-human trial for its new transcatheter aortic valve. Study doctors successfully implanted the device...
CardiAQ, Edwards, acquire, acquisition, Fortis, TMVI, mitral valve replacement
Edwards Lifesciences Corp. announced that it has agreed to acquire CardiAQ Valve Technologies Inc., a privately held company and developer of a transcatheter...
Medtronic, CoreValve Evolut R, FDA approval, TAVR, recapturable
The recapturable, self-expanding CoreValve Evolut R System from Medtronic is approved for transcatheter aortic valve replacement (TAVR) in
The Edwards Sapien 3 valve with the Commander Delivery System is indicated for the treatment of high-risk patients suffering from severe,...
The latest release of the 3mensio Structural Heart platform from Pie Medical Imaging contains an optimized Mitral workflow and a new Septal...
The CoreValve self-expanding transcatheter aortic valve replacement (TAVR) system is now cleared for an additional indication to treat...

Articles

CardiAQ, Edwards, acquire, acquisition, Fortis, TMVI, mitral valve replacement
Edwards Lifesciences Corp. announced that it has agreed to acquire CardiAQ Valve Technologies Inc., a privately held company and developer of a transcatheter...
sentraheart lariet, LAA occlusion, FDA safety alert
The U.S. Food and Drug Administration (FDA) is alerting healthcare providers and patients of reports of patient deaths and other serious adverse events...
CardiAQ Valve Technologies, TMVI, second generation, implantation, Tor Vergata
CardiAQ Valve Technologies (CardiAQ) announced that its second-generation transcatheter bioprosthetic mitral heart valve was successfully implanted as a...
REDUCE FMR, Cardiac Dimensions, Carillon Mitral Contour System, FMR
Cardiac Dimensions announced the first patients have been enrolled in the REDUCE FMR clinical trial. REDUCE FMR is a prospective, double-blind, randomized...

Video Center

Here are a few observations on cardiovascular ultrasound advances I made while attending the 2015...
4 weeks 16 hours ago
The latest advances in cardiovascular echocardiography will be presented at the 2015 American...
6 weeks 3 days ago
There were several technology takeaway messages for the future of electrophysiology (EP) at the...
9 weeks 3 days ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...